Correlation Between UPM Kymmene and Herantis Pharma

Can any of the company-specific risk be diversified away by investing in both UPM Kymmene and Herantis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UPM Kymmene and Herantis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UPM Kymmene Oyj and Herantis Pharma Oyj, you can compare the effects of market volatilities on UPM Kymmene and Herantis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UPM Kymmene with a short position of Herantis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of UPM Kymmene and Herantis Pharma.

Diversification Opportunities for UPM Kymmene and Herantis Pharma

0.25

Correlation Coefficient

UPM Kymmene  Herantis Pharma

Modest diversification

The 3 months correlation between UPM and Herantis is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding UPM Kymmene Oyj and Herantis Pharma Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Herantis Pharma Oyj and UPM Kymmene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UPM Kymmene Oyj are associated (or correlated) with Herantis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Herantis Pharma Oyj has no effect on the direction of UPM Kymmene i.e., UPM Kymmene and Herantis Pharma go up and down completely randomly.

Pair Corralation between UPM Kymmene and Herantis Pharma

Assuming the 90 days trading horizon UPM Kymmene Oyj is expected to under-perform the Herantis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, UPM Kymmene Oyj is 1.86 times less risky than Herantis Pharma. The stock trades about -0.1 of its potential returns per unit of risk. The Herantis Pharma Oyj is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  144.00  in Herantis Pharma Oyj on September 29, 2024 and sell it today you would earn a total of  5.00  from holding Herantis Pharma Oyj or generate 3.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

UPM Kymmene Oyj  vs.  Herantis Pharma Oyj

UPM Kymmene Oyj

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days UPM Kymmene Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Herantis Pharma Oyj

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Herantis Pharma Oyj are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, Herantis Pharma is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with UPM Kymmene and Herantis Pharma

The main advantage of trading using opposite UPM Kymmene and Herantis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UPM Kymmene position performs unexpectedly, Herantis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Herantis Pharma will offset losses from the drop in Herantis Pharma's long position.

The idea behind UPM Kymmene Oyj and Herantis Pharma Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..